SAMANTHA CHILDERS: Open Payments
NPI 1467972711 · FLATWOODS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 104 payments from 16 companies in 2025. Trend: 2023 $1,260 · 2024 $1,263 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 26 | $382 |
| ABBVIE INC. | 18 | $336 |
| GlaxoSmithKline, LLC. | 15 | $196 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $162 |
| Novo Nordisk Inc | 8 | $152 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| Lilly USA, LLC | 5 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45 |
Products named: VRAYLAR, NURTEC ODT, TRELEGY ELLIPTA, XIFAXAN, ELIQUIS, QULIPTA, REXULTI, MOUNJARO.
Industry payments across KY — which companies pay providers there.
